Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization-Reference-Cited by-同舟云学术

Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization

Published:2022-12-01 Issue:6 Volume:187 Page:1007-1008
ISSN:1365-2133
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Mrowietz Ulrich¹^ORCID,Augustin Matthias²^ORCID

Affiliation:

1. Psoriasis-Center, Department of Dermatology University Medical Center Schleswig-Holstein Campus Kiel Kiel Germany

2. German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP) University Medical Center Hamburg-Eppendorf (UKE) Hamburg Germany

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21827

Reference5 articles.

1. Definition of treatment goals for moderate to severe psoriasis: a European consensus

2. Topology of psoriasis in routine care: results from a high-resolution analysis in 2009 patients;Augustin;Br J Dermatol,2019

3. Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey;Griffiths;J Eur Acad Dermatol Venereol,2018

4. Treatment goals in psoriasis routine care;Radtke;Arch Dermatol Res,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of initiating biologics in the treatment of psoriasis;International Journal of Dermatology;2024-08-07

2. Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G‐EPOSS study;Journal of the European Academy of Dermatology and Venereology;2024-04-11

3. Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial;Journal of the American Academy of Dermatology;2023-10

4. Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey;Dermatology and Therapy;2023-05-15

5. Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe;Advances in Therapy;2023-03-02